v3.25.2
Stockholders’ Equity (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Equity [Abstract]    
Summary of Warrant Activity

The following is a summary of the warrant activity for the six months ended June 30, 2025:

 

   Number of
Warrants
   Average
Exercise Price
   Weighted
Average
Remaining
Contractual
Term in Years
 
             
Outstanding at January 1, 2025   245,192   $17.50    2.02 
Exercisable at January 1, 2025   245,192   $17.50    2.02 
Granted   -    -    - 
Exercised / surrendered   -    -    - 
Expired   -    -    - 
Outstanding at June 30, 2025   245,192   $17.50    1.52 
Exercisable at June 30, 2025   245,192   $17.50    1.52 

The following is a summary of the warrant activity for the year ended December 31, 2024:

 

  

Number of

Warrants

  

Average

Exercise Price

  

Weighted Average

Remaining

Contractual

Term in Years

 
             
Outstanding at January 1, 2024   245,192   $17.50    3.02 
Exercisable at January 1, 2024   245,192   $17.50    3.02 
Granted   -    -    - 
Exercised / surrendered   -    -    - 
Expired   -    -    - 
Outstanding at December 31, 2024   245,192   $17.50    2.02 
Exercisable at December 31, 2024   245,192   $17.50    2.02 
Schedule of Stock Option Activity  

Stock option activity under the Company’s stock-based compensation plans is shown below:

 

  

Number of

Shares

  

Average Exercise

Price per Share

  

Weighted Average

Remaining

Contractual

Term in Years

 
             
Outstanding at January 1, 2024   13,400   $14.55    0.82 
Exercisable at January 1, 2024   13,400    14.55    0.82 
                
Granted   -    -    - 
Exercised   -    -    - 
Forfeited   13,400    14.55    - 
Outstanding at December 31, 2024   -    -    - 
Exercisable at December 31, 2024   -    -    - 

 

(1) The intrinsic value of the stock options at December 31, 2024 is the amount by which the market value of the Company’s common stock of $0.67 as of December 31, 2024 exceeds the average exercise price of the option. As of December 31, 2024, the intrinsic value of the outstanding and exercisable stock options was nil.